BRIGHT-4 trial: bivalirudin strikes back.
Lancet
; 401(10383): 1157-1158, 2023 04 08.
Article
in En
| MEDLINE
| ID: mdl-37030888
Full text:
1
Database:
MEDLINE
Main subject:
Antithrombins
/
Hirudins
Limits:
Humans
Language:
En
Journal:
Lancet
Year:
2023
Type:
Article